Regulatory Affairs Headv2.1.1

A healthtech startup developing a Class II diagnostic device needs to prepare a 510(k) submission to the FDA. This involves identifying a predicate device, compiling performance testing data, and drafting a substantial equivalence argument to secure market clearance in the US.

A medtech company launching an AI-based clinical decision support tool must achieve CE marking under EU MDR 2017/745. This requires developing technical documentation, conducting a clinical evaluation, and engaging a Notified Body for conformity assessment to access the European market.

A medical device manufacturer with a novel Class III implant needs to coordinate regulatory approvals across the US (via PMA), EU, Canada, and Japan. This involves developing a multi-market strategy, managing clinical evidence requirements, and aligning timelines to optimize global launch.

A company receives a deficiency letter from the FDA requesting additional information on their 510(k) application. They must analyze the queries, gather supplementary data or clarifications, and draft a comprehensive response to address the agency's concerns and avoid submission rejection.

Offering specialized consulting to healthtech and medtech firms for FDA submissions, EU MDR compliance, and global market access. Revenue is generated through project-based fees or retainer agreements, with pricing based on submission complexity and regulatory pathway.

Providing a subscription-based software tool that tracks evolving regulations, standards, and agency guidance for medical devices. Revenue comes from monthly or annual licenses, with tiered pricing for small startups to large enterprises.

Acting as an external regulatory team for companies lacking in-house expertise, managing end-to-end processes from strategy to submission. Revenue is based on full-time equivalent (FTE) contracts or outcome-based success fees tied to approval milestones.